NIAID recruited the 400 US volunteers for Dr. Fauci’s remdesivir trial.16 Dr. Fauci’s press release said only that remdesivir “has shown promise in animal models for treating Middle East Respiratory Syndrome (MERS).”17 It’s unclear, then, if NIAID informed these frightened souls that, less than a year earlier, a safety review board had deemed remdesivir unacceptably toxic.
